PERIOCHIP Drug Patent Profile
✉ Email this page to a colleague
When do Periochip patents expire, and when can generic versions of Periochip launch?
Periochip is a drug marketed by Dexcel Pharma and is included in one NDA.
The generic ingredient in PERIOCHIP is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Periochip
A generic version of PERIOCHIP was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PERIOCHIP?
- What are the global sales for PERIOCHIP?
- What is Average Wholesale Price for PERIOCHIP?
Summary for PERIOCHIP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 5 |
| Patent Applications: | 6,899 |
| What excipients (inactive ingredients) are in PERIOCHIP? | PERIOCHIP excipients list |
| DailyMed Link: | PERIOCHIP at DailyMed |
Recent Clinical Trials for PERIOCHIP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Dexcel Pharma Technologies Ltd. | Phase 3 |
| Dexcel Pharma Technologies Ltd. | Phase 2 |
US Patents and Regulatory Information for PERIOCHIP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dexcel Pharma | PERIOCHIP | chlorhexidine gluconate | TABLET;DENTAL | 020774-001 | May 15, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PERIOCHIP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dexcel Pharma | PERIOCHIP | chlorhexidine gluconate | TABLET;DENTAL | 020774-001 | May 15, 1998 | ⤷ Sign Up | ⤷ Sign Up |
| Dexcel Pharma | PERIOCHIP | chlorhexidine gluconate | TABLET;DENTAL | 020774-001 | May 15, 1998 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PERIOCHIP
See the table below for patents covering PERIOCHIP around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Israel | 78826 | PRECURSOR COMPOSITION FOR THE PREPARATION OF A BIODEGRADABLE IMPLANT FOR THE SUSTAINED RELEASE OF AN ACTIVE MATERIAL AND SUCH IMPLANTS PREPARED THEREFROM | ⤷ Sign Up |
| Greece | 3006681 | ⤷ Sign Up | |
| Spain | 2044925 | ⤷ Sign Up | |
| Australia | 7480687 | ⤷ Sign Up | |
| Canada | 1307463 | COMPOSITIONS PHARMACEUTIQUES A LIBERATION PROLONGEE (SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS) | ⤷ Sign Up |
| Canada | 2011637 | COMPOSES POUR LA LIBERATION SOUTENUE DE CHLORHEXIDINE (COMPOSITIONS FOR THE SUSTAINED-RELEASE OF CHLORHEXIDINE) | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
